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The hormesis concept demonstrates that in contrast to the toxic effect of high
doses of materials, irradiation, etc., low doses of them are beneﬁcial and, in addition,
help to eliminate (prevent) the deleterious effect of high doses given after it. By this
effect, it is an important factor of (human) evolution protecting man from harmful
impacts, similarly to the role of immunity. However, immunity is also continuously
inﬂuenced by hormetic effects of environmental [chemical (pollutions), physical
(background irradiations and heat), etc.] and medical (drugs and therapeutic irradia-
tions) and food interactions. In contrast to earlier beliefs, the no-threshold irradiation
dogma is not valid in low-dose domains and here the hormesis concept is valid. Low-
dose therapeutic irradiation, as well as background irradiations (by radon spas or
moderately far from the epicenter of atomic bomb or nuclear facilities), is rather
beneﬁcial than destructive and the fear from them seems to be unreasonable from
immunological point of view. Practically, all immune parameters are beneﬁcially
inﬂuenced by all forms of low-dose radiations.
Keywords: background irradiation, immune functions, hormetic effects,
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Introduction
The toxicological notion of hormesis is well known since centuries;
however, it was not studied thoroughly from medical standpoint [1]. At the
beginning of the 21st century, the works of Calabrese [2–6] brought it in the
frontline of medicine and since then a mass of papers had been published
approaching different aspects theoretically and practically (clinically) alike [7].
Hormesis demonstrates the beneﬁcial effect of an environmental factor,
drug, occupational pollutant, natural, artiﬁcial irradiation, etc., which is toxic
(harmful) in high doses; however, it is innocuous, even beneﬁcial if affects in
small dose or doses. In addition, the pretreatment with this hormetic dose is
conditioning against the deleterious effect of toxic dose given afterward [8, 9].
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In general, the phenomenon of hormesis can be found in the whole animal world
in the nature, in experimental objects as well as in human beings. It was
developed during the evolution, protecting the living world from deleterious
effects as it is done by the immune system, but preceding this latter and also
collaborating with it. It is estimated that centuries ago, the natural background
radiation was about ﬁvefold larger than in recent times and mammals could
survive with the help of hormesis [10].
The hormetic effect can be activated by stressors, which activate
cellular signal molecules as gases (oxygen, carbon monoxide, and nitric
oxide), the neurotransmitter glutamate, calcium ion, tumor necrosis factor
(TNF), etc.
The quality and quantity of immune functions are strongly inﬂuenced by
hormesis, and this can be demonstrated and clearly measured by studying the
effect of irradiation directly on the immune system (cells or products) or on the
diseases inﬂuenced by the state of the immunity. Irradiation is a good test for
studying the hormetic effect, as it is easily measurable, doses can be changed, and
its deleterious, as well as therapeutic effects are well known in high doses. In
addition, it is very frequently used for treating human diseases. However, its
deleterious effect was recognized when its discoverers had serious signs of
destructions and since then it was registered as a dangerous tool and the fear
from it was characteristic to man. A long time passed up to the recognition of
beneﬁcial effects of low-dose irradiation and longer time up to the acceptance of
beneﬁcial radiation hormesis. The linear no-threshold (LNT) hypothesis was
accepted for more than hundred years, believing that the irradiation is harmful
in any doses and that large dose is very harmful, while small (low) dose is also a
little bit harmful; however, small doses are collected and they are approaching a
level, when they become deleterious. This imagination was also valid to the
relation between the irradiation and immune system. However, since the LNT
hypothesis had lost its dominance, the beneﬁcial effect of low-dose irradiation
won its place as stimulator (benefactor) of immunity.
Effect of Hormetic Irradiation on Immunity
When immunity is studied, there is a possibility for measuring direct
immune response by counting cell numbers and proportions, amount of
antibodies, etc., however, knowing the role of immunity also in the ﬁghting
against different diseases (infections, tumor development and mortality,
lifespan, etc.) by the state of them. As a sum, it shows the functional condition
of the immune system.
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Effects on the immune cells
In general, high-dose irradiation causes the suppression of immunity and
low-dose irradiation stimulates immunity [11, 12]. This is a typical case of hormesis
and it can be used clinically in the radiation treatment of numerous diseases [11].
The low-dose irradiation enhances the proliferation of immune cells as well as the
interactions of innate and adaptive immune systems [13, 14]. The low-dose
irradiation positively inﬂuences numerous cell types of the immune system, such
as natural killer (NK) cells [15], dendritic cells [16], T lymphocytes [11], especially
helper T lymphocytes [17], B lymphocytes, and macrophages [18–21].
Cytokine production by macrophages and splenocytes is stimulated by low doses
of X-rays [22].
NK cell proliferation and activity were enhanced and also their cytotoxic
functions by synergizing them [23–25]. The secretion of cytokines, such as IL-2,
IL-10, IL-12, interferon gamma, and TNF-α, had also been stimulated [22, 26].
IL-12 production of dendritic cells was also activated [27]. Apoptosis was
decreased in NK cell and dendritic cell populations [28]. Chronic low-dose
irradiation activated the immune system of the whole body [27]. At the same
time, this could modulate the capacity of bone marrow cells to differentiate into
dendritic cells. The immunomodulatory alterations stimulate the immune system
to kill neoplastic cells in experimental animals and man [29]. In the bone
marrow, hematopoietic cells are proliferating under the effect of low-dose
whole-body irradiation [30]. This is also supported by observations demonstrat-
ing that people living near nuclear power plants have higher than normal blood
cell count [31].
Annual doses of irradiation not higher than twice the natural radiation exert
positive effect on DNA damage repair in white blood cells, thereby increasing
cellular resistance (and decreasing oxidative stress) [32–34]. In mice, continuous
low-dose whole-body irradiation stimulated the immune functions.
It seems to be possible that the hormetic effect on the immune system is
taking place via glutathionylation [35, 36].
Effects on cancer
Low-dose ionizing radiation can cause reduction in tumor development [37],
and in animal (rat) experiments, metastasis formation was suppressed by it
[38, 39]. Such low dose of single irradiation (0.1 Gy) suppresses the development
of experimental (mice) tumor metastases, likely by the stimulation of NK cell
functions [40]. Human observations show that low-dose radiation exposure
decreases human cancer incidence and mortality, by enhancing anticancer
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immunity [40, 41]. What seems to be the most important is that the low-dose
radiation causes cell proliferation in human embryonic lung ﬁbroblasts, while it
does not affect lung cancer cells [42].
Background Irradiation
Background irradiation is a low-dose irradiation, which has a natural (in spas
and in high-altitude spaces), or artiﬁcial (i.e., human made, such as nuclear
facilities, isotope laboratories, X-ray treatments, and diagnostics), or mixed (as in
man-made buildings, where the irradiation is coming from the clay of bricks)
source [43].
Radon is a gas, which is radioactive and comes from the natural breakdown of
uranium, thorium, and radium in the soil and groundwater. People are breathing or
drinking radon and its soluble form is used as a curative substance in certain spas. It
can be found in the air of many buildings causing lower or higher irradiation of the
owners’ homes. It was believed earlier that radon concentrations of homes are
dangerous, causing lung cancer; however, at present, the opinion is the opposite,
i.e., radon helps to avoid lung cancer that would be caused by smoking [44, 45] and
to stimulate DNA-repair and apoptosis. Dose-response data from studies of nuclear
workers suggest that about 0.4 cGy/month is beneﬁcial and responsible for
enhanced immune competence [46]. Low-dose radon-spa therapy provoked a
long-lasting increase in T cells, monocytes, and neutrophils and eosinophils as
well as dendritic cells were temporarily modulated after therapy [47].
It is known that radon of mines and spas as well as thorium-bearing
monazite sands and enhanced radioactive uranium obtained from a natural
geological reactor are suitable for treating inﬂammations and carcinous alterations
[48]. In animal models, water-dissolved radon suppressed atopic dermatitis and
tumor metastasis in mice [49]. In high-level radon-rich areas of Iran, the
inhabitants have higher level of IL-4 and more responsive immune system
[50]. Similar observations were done in radon-exposed mice [51].
When 290 male subjects who were exposed to only 50–149 cGy in Nagasaki
(Japan) showed a lower mortality compared with unexposed males, it is a peculiar
indirect proof that the beneﬁcial effect of low-dose irradiation to the immune
system is the effect of peripheral A-bomb radiation [52]. In the United States, there
are such areas (counties) that are settled in planes or in elevations. In the higher
settled areas, the cancer mortality was about 54/100,000, whereas in counties at the
plain, it was about 74 and the signiﬁcance between the two values was strongly
signiﬁcant [53]. By the comparison of counties where nuclear testing occurred
with other counties without nuclear testing and the analysis of lung cancer
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incidence, it was found that the more background radiation exposure was
associated with less lung cancer [54]. A similar case was found in Taiwan, where
recycled steel contaminated with cobalt 60 was used in groups of apartment
buildings. Cobalt 60 is radioactive with a half life of 5.3 years. People who were
living in these apartments received 40 mSv/year. When the cancer death rate was
reviewed, it was clear that during the time period it was studied, deaths from
cancer averaged 3.5/100,000 person-years for the cobalt-60 irradiated population,
as compared with 116 per 100,000 person-years for the general population of
Taiwan, which means a 33-fold reduction in cancer deaths, instead of the earlier
(LNT) expected increase [55].
Considering human observations, e.g., in India, it was found that where the
background radiation was higher, the cancer risk was invariably less [56]. In a spa
area in Japan, with a high radon background, the stomach and lung cancer rates
were less compared to that in the whole Japanese population [57] and inside the
nuclear facilities (workers) or around them (inhabitants), higher cancer morbidity
or mortality was not found [58, 59], and also reduction of certain cancer incidence
was observed [60].
There could be a background radiation for an organ caused by the
therapeutic high-dose irradiation of another organ. In the case of the irradiation
of breast cancer or rectosigmoid cancer, ovary gets low-dose background irradia-
tion. This could reduce the risk of ovarian cancer by 44% [61].
Autoimmunity and Allergy
Low-dose irradiation ameliorates arthritis and other autoimmune diseases
[62]. Repeated low-dose (0.5 Gy) treatment attenuated experimental autoimmune
encephalitis through suppression of inﬂammatory cytokines, reduction of cytotoxic
T cells, and stimulation of Treg cells [63] and suppressed the proliferation of
CD3+CD4−CD8−B220+T cells as well as the synthesis of IL-6 and autoantibodies
[64]. Similar effects were observed in the case of collagen-induced arthritis, where
suppression of proinﬂammatory cytokines and autoantibody production as well as
induction of Treg cells were observed [65]. In a model of systemic lupus
erythematosus, the suppression of development of the disease was observed
[14]. Ultraviolet (UV) light could help to prevent certain autoimmune disorders [66].
Effects on Infections
According to Calabrese [67], at least 90 immune-system-related
hormetic-like responses were studied and 100 drugs as well as 70 endogenous
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agonists, which demonstrate the hormetic effect and these decrease the extent
of infection-associated tissue damage without directly targeting pathogenic
microorganisms [68–70].
Effects of Nutrition
Dietary restriction and fasting prevent or lessen the severity of cancer, and
autoimmune diseases [71] caused changes in the development of B and T cells in
primary and secondary lymphoid organs [72]. The protecting hormetic effect of
mild air pollution against DNA damage does not interact with diet factors in
lymphocytes of pregnant women [73]. Observations on honeybees showed that
after eating insecticide (thiacloprid)-polluted foods, the bees had signiﬁcantly
longer lifespan [74].
Conclusions
The hormetic effect seems to be surprising; however, it is absolutely normal,
if we start from another end of the story. If we are studying a substance which is
beneﬁcial using in a low dose and toxic or has altered properties using high doses,
this seems to be a natural thing. However, in the present case of hormesis,
substances (or irradiation) were studied, registered earlier as toxic in higher doses
and the quality of the effect was different (opposite) in lower dose.
According to Luckey [46, 75], the background radiation is gradually dimin-
ished during millions of years and during the presence of man in the earth and the
modern humans are now living in a radiation-deﬁcient world. However, some
background radiation is needed for repair and detoxiﬁcation and the deﬁciency is
substituted by natural or artiﬁcial low-dose irradiation. It is also supposed that
supplementation with about 0.4 cGy/month is beneﬁcial, not destructive and it is
not only tolerable, but also necessary for the normal life [46]. This “chemo-defense
system” could have been developed before the establishment of the immune system
in the ﬁrst living organisms of the earth [76, 77].
The general opinion – the fear – on the effect of low irradiation must be
changed, as this was overestimated [78, 79]. A series of observations show that
the fear of cancer caused by low-dose radiation effects is baseless, although
people were moved away and buildings were demolished because of believing
the danger of radiating building materials. Microdoses of substances (insecti-
cides, pesticides, etc.) in or on the food hindered people from eating healthy
fruits or vegetables. Considering the microdoses of herbicides and pesticides on
the surface of the washed fruits, it can be imagined (although there are not
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enough investigations) that they have hormetic effects and contribute to our
longer lifespan, by stimulating immunity [80].
A special problem is the hormesis that is executed during the prenatal age or
perinatally. In this period, the cells and the organs containing them are more
sensitive to stress-like inﬂuences and hormetic effects can cause lifelong altera-
tions. This can be expressed by the faulty hormonal imprinting [81], in which the
extremely sensitive hormone receptors [82] are touched or the late hormone
production, both strongly inﬂuenced people’s innate and adaptive immunity, as
well as the hormone synthesis by immune cells [83]. As hormesis and hormonal
imprinting are epigenetic processes alike [84, 85], the alterations are inherited to
the progenies of cells and progenies of the individuum. A faulty perinatal
hormonal imprinting can be deteriorating; however, it can also be beneﬁcial,
considering hormesis [86]. It is supposed that lower cancer incidence in develop-
ing nations is caused by “mimotope” hormesis, the hormetic effect of infections in
the early periods, which develops a fortiﬁcation of the immune system [87].
Although this theory is not exactly supported, it is not rejectable. As in our modern
age, there are a mass of environmental and medicinal pollutants and chemicals
stressing the organisms during early development, these effects are causing
permanent traces in the victims and their progenies [88–93]. However, the basic
problem is the extremely increasing amount and quality of endocrine disruptors,
which acting in the pre- and perinatal periods could transform the immune system
for life, causing immunodeﬁciency, allergy, and autoimmune diseases as well as
the lost of defense against malignant diseases [94–96].
The state of immunity has a very important role in the defense against tumor
formation and growth. However, its effect is characterized as a two-edged sword,
as the direction of effect is dependent on many factors [97–101]. Tumor-directed
immune reactants in low doses stimulate tumor growth, while it blocks tumor
growth in higher doses [102–104]. In contrast to this, low-dose radiation increases
immunity against cancer, by elevating anticancer parameters and retards metasta-
sis formation, whereas high doses of it stimulates cancer growth. In addition, it
inhibits carcinogenicity caused by high doses of radiation [102]. In general, cancer
surveillance is increasing under the effect of low-dose irradiation [103–105].
All of the new data conclude that the earlier LNT hypothesis, which registered
any radiation as harmful, is scientiﬁcally not proven and must be substantiated
with the consideration of hormesis [106, 107]. This means that cancer chemo-
therapy and radiation therapy hormesis request the ﬁnding of doses, which are
immunogenic, instead of deleterious [108–110]. However, not only irradiation or
chemotherapy requires transformation of employment, but also other stressors
could be employed, e.g., cold stress is recommended for cancer therapy through
immune stimulation [111].
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It is very interesting that hormesis shows some gender speciﬁcity. As it
was mentioned, atomic bomb survivors who had low-dose irradiation are less
sensitive to non-cancerous diseases than the irradiation-free population. How-
ever, this is valid only to males and NK cell activity was also higher in males
than in females [112]. Similarly, in Drosophila, there is a gender-speciﬁc impact
of thermal hormesis [113, 114] and infection hormesis [115]. Therefore, the
manifestation in males is always dominant as it is happened in the case of atomic
bomb survivors.
It is believed that there are certain speciﬁc places for background irradiation.
However, some low-dose background irradiation is always present in more sites,
in the form of, e.g., UV irradiation, from the beach to the long spaceﬂights [116].
This can also inﬂuence (prevent) some pathological processes [66, 117, 118],
while in high doses it is deleterious.
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